Bristol-Myers Squibb Co

DUS:BRM

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BRM's stock price target?

Price Target

59.41 EUR

According to Wall Street analysts, the average 1-year price target for BRM is 59.41 EUR with a low forecast of 34.6 EUR and a high forecast of 71.95 EUR.

What is the Revenue forecast for Bristol-Myers Squibb Co?

Projected CAGR

-3%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.

What is the Gross Profit forecast for Bristol-Myers Squibb Co?

Projected CAGR

-2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is -2%.

What is the Operating Income forecast for Bristol-Myers Squibb Co?

Projected CAGR

-2%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.

What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?

Projected CAGR

15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Bristol-Myers Squibb Co?

Projected CAGR

7%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.